Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

RARE PHOTOS: 6 - The Real Truth

If You Could Only Own 3 Stocks, It Should Be These

Consumer sentiment has been buoyed by the recent cooldown in inflation and encouraging economic data. However, with interest rate hikes expected to continue, the risk of the economy tipping into a recession remains. Hence, fundamentally strong stocks Coca-Cola (KO), Merck & Co (MRK), and Valero Energy (VLO) that pay reliable…

StockNews.com

5 Top Stocks to Buy for 2023

The stock market witnessed a solid start this year amid improving investors’ optimism. Moreover, experts see increased chances of a soft landing. So, fundamentally strong stocks Merck (MRK), Novartis (NVS), Sysco (SYY), Progress Software (PRGS), and LSI Industries (LYTS) could be solid buys now. These stocks pay consistent dividends. Read…

StockNews.com

3 Stocks for Long-Term Investors to Buy in 2023

As inflation shows signs of cooling, the Fed has significantly slowed its aggressive rate hike policy. Moreover, given a tight labor market, experts believe the economy might avoid a recession. Amid the rising optimism, we think quality stocks Merck (MRK), PepsiCo (PEP), and Limbach (LMB) are ideal buys for long-term…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Stocks It Is Time to Buy Now

Although headline inflation has slowed, the Fed will likely keep raising interest rates to attain its 2% target. However, a potential slowdown in monetary policy tightening is opening the path for quality stocks to recover. Therefore, investors should consider buying fundamentally sound stocks Merck & Co. (MRK), Novartis (NVS), and…

StockNews.com

The 3 Best Large-Cap Stocks to Buy Now and Hold Forever

Although the latest inflation and employment reports indicate a resilient economy, the Fed’s persistence to keep interest rates high has caused widespread concerns about an economic slowdown. With uncertainties surrounding the economy, we think it could be wise to buy and hold large-cap stocks Merck & Co. (MRK), Coca-Cola (KO),…

StockNews.com

3 Stocks to Help Protect Your Portfolio Through 2023

With the Fed likely to go ahead with its interest rate hikes this year, the market will likely remain under pressure. Given the foreseen volatility in the stock market, investors might consider investing in stable and dividend-paying stocks Merck & Co. (MRK), Elevance Health (ELV), and Waste Management (WM) to…

StockNews.com

The 3 Best Retirement Stocks to Buy for Investors Over 55

While moderation of the inflation rate is December has triggered a bear market rally, the stock market is unlikely to stabilize in the near term because of the likelihood of further interest rate hikes. Hence, shares of fundamentally strong and growing businesses with a track record of increasing dividend payouts,…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 Stocks to Buy Like There's No Tomorrow

While inflation eased considerably for two consecutive months, the Fed signaled to keep raising interest rates through this year. The potential continuation of rate hikes has fueled recessionary concerns. Amid an uncertain macroeconomic backdrop, it could be wise to buy fundamentally strong stocks Merck (MRK), Biogen (BIIB), and MasterCraft Boat…

StockNews.com

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

StockNews.com

1 Pharma Stock That Could Head Even Higher Next Year

Pharma company Merck & Co. (MRK) is attempting to broaden its portfolio through collaborations and acquisitions. The company looks poised for growth in 2023. So, the stock might be a solid buy now. Read on….

StockNews.com

3 Stocks to Buy to Build a Millionaire Portfolio

Inflation eased for the second consecutive month in November, and the Fed slowed down the pace of rate hikes after four straight 75-basis-point hikes. However, recession fears loom as the central bank plans to raise rates through next year. Regardless of the economic uncertainties, it could be wise to invest…

StockNews.com

New to Investing? Give These 2 Robust Stocks a Try

Despite the recent wild swings in the stock market, experts believe stocks to stabilize next year. However, as uncertainties remain, new investors should consider investing in stocks that offer compelling yields, such as Merck & Co (MRK) and Verizon Communications (VZ). Keep reading….

StockNews.com

4 Pharmaceutical Stocks You Can Always Rely On

The pharmaceutical industry is well-positioned to witness substantial growth, driven by the prevalence of chronic diseases, the aging population, and increased healthcare spending. Given the industry’s promising growth prospects, we think it could be wise to invest in fundamentally sound pharmaceutical stocks Johnson & Johnson (JNJ), Merck & Co (MRK),…

StockNews.com

2 Stocks Wall Street Always Likes to Stick With

The Fed’s aggressive monetary policy stance has created widespread recession possibilities for next year. However, stable consumer spending and a hot labor market shows signs of a resilient economy. Amid this scenario, Wall Street favorites Microsoft (MSFT), and Merck & Co. (MRK) could be worth buying, considering their fundamental strength.…

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Is Merck & Co. Stock Worth Buying Before the End of 2022?

Healthcare company Merck & Co. (MRK) is set to acquire Imago BioSciences (IMGO) for more than $1 billion. The stock has gained more than 40% this year. However, given the macroeconomic headwinds, would it be wise to buy the stock now? Read on to find out….

StockNews.com

3 Stocks Insiders Can’t Stop Buying This Month

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

StockNews.com

4 Stocks to Buy That Have Caught Wall Street's Attention

With strong indications of slowing interest rate hikes by the Fed poised to feed the stock market rally, it could be wise to invest in Merck (MRK), AT&T (T), Mosaic (MOS), and Photronics (PLAB), which are in vogue on Wall Street. Continue reading….

StockNews.com

2 Stocks the Smart Money on Wall Street Owns the Majority Right Now

The Federal Reserve is expected to lower the pace of its rate hikes from next month. However, concerns about an economic slowdown are still evident. Hence, this might be the time to follow the smart money and buy Merck (MRK) and Yelp (YELP). Institutions own the majority of shares of…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Stocks to Buy Before 2022 Comes to an End

With the Fed indicating that the final level of interest rates will be higher than expected, many analysts expect the economy to slip into a recession next year. Since the stock market will likely remain under pressure, investors should consider buying fundamentally strong stocks UnitedHealth Group (UNH), Merck & Co.…

StockNews.com

2 Stocks That Are Too Good of Buying Opportunities to Ignore

The latest CPI report shows signs of a cooling down inflation. On the other hand, the healthcare market is expected to boom amid increasing health awareness and technological advancements. Hence, we think fundamentally robust healthcare stocks Merck & Co. (MRK) and Elevance Health (ELV) could be solid investments now. Read…

StockNews.com

Hot Stocks to Buy? 3 Medical Stocks to Consider Now

The healthcare industry tends to withstand challenging macro conditions relatively well, as it enjoys inelastic demand for its products and services. And given the solid long-term prospects of the industry, it could be wise to load up fundamentally sound medical stocks Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck (MRK)…

StockNews.com

3 Strong Buy Stocks Begging to Be Bought in Q4

The Federal Reserve announced its fourth consecutive 75-bps rate hike yesterday. As the chances of the economy falling into a recession are tightening, fundamentally strong and resilient stocks Merck & Co (MRK), Biogen (BIIB), and Kroger (KR), which are rated Strong Buy in our proprietary rating system, could be safe…

StockNews.com

This Health Care Stock Is a No-Brainer Buy for Fall

Merck & Co.’s (MRK) third-quarter financials surpassed Wall Street’s expectations. The stock is trading near its 52-week high of $101.50, and its momentum is expected to continue, considering its strong fundamentals. Given the company’s solid growth, reliable dividend payments, and the resilience of its sector against the expected economic slowdown,…

Benzinga

What Are Whales Doing With Merck & Co

A whale with a lot of money to spend has taken a noticeably bullish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 21 strange trades.

StockNews.com

3 Safe Stocks for Retirees to Buy This Fall

Market volatility is rife ahead of the Fed’s potentially aggressive rate hike in its meeting next month. With consecutive rate hikes, a recession seems unavoidable. Amid the uncertainties, we think fundamentally sound stocks Merck (MRK), Cisco Systems (CSCO), and Ryerson Holding (RYI), which pay a reliable dividend, could be safe…

1 … 5 6 7 8

People

Kritika SarmahHer

727 stories

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.